Global OTC Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global OTC Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Non-prescription drugs refer to drugs that can be purchased for the convenience of the public without a prescription from a physician or other medical professional. The general public can use the drugs on their own discretion according to the drug labels and instructions.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the OTC Drug industry chain, the market status of Hospital (Class A OTC Drug, Class B OTC Drug), Clinic (Class A OTC Drug, Class B OTC Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of OTC Drug.
Regionally, the report analyzes the OTC Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global OTC Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the OTC Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the OTC Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Class A OTC Drug, Class B OTC Drug).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the OTC Drug market.
Regional Analysis: The report involves examining the OTC Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the OTC Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to OTC Drug:
Company Analysis: Report covers individual OTC Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards OTC Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to OTC Drug. It assesses the current state, advancements, and potential future developments in OTC Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the OTC Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
OTC Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe OTC Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of OTC Drug, with revenue, gross margin and global market share of OTC Drug from 2019 to 2024.
Chapter 3, the OTC Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and OTC Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of OTC Drug.
Chapter 13, to describe OTC Drug research findings and conclusion.
Non-prescription drugs refer to drugs that can be purchased for the convenience of the public without a prescription from a physician or other medical professional. The general public can use the drugs on their own discretion according to the drug labels and instructions.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the OTC Drug industry chain, the market status of Hospital (Class A OTC Drug, Class B OTC Drug), Clinic (Class A OTC Drug, Class B OTC Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of OTC Drug.
Regionally, the report analyzes the OTC Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global OTC Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the OTC Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the OTC Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Class A OTC Drug, Class B OTC Drug).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the OTC Drug market.
Regional Analysis: The report involves examining the OTC Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the OTC Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to OTC Drug:
Company Analysis: Report covers individual OTC Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards OTC Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to OTC Drug. It assesses the current state, advancements, and potential future developments in OTC Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the OTC Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
OTC Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Class A OTC Drug
- Class B OTC Drug
- Hospital
- Clinic
- Household
- Bayer HealthCare
- GlaxoSmithKline(GSK)
- Johnson&Johnson
- Pfizer
- Sanofi
- AstraZeneca
- BioGaia
- Bristol Myers Squibb
- Bukwang Pharmaceutica
- Chr. Hansen
- Cipla
- CoLucid
- Daiichi Sankyo
- Friggs
- DSM
- Eisai
- Eli Lilly
- Herbalife
- Euradite
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe OTC Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of OTC Drug, with revenue, gross margin and global market share of OTC Drug from 2019 to 2024.
Chapter 3, the OTC Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and OTC Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of OTC Drug.
Chapter 13, to describe OTC Drug research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of OTC Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of OTC Drug by Type
1.3.1 Overview: Global OTC Drug Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global OTC Drug Consumption Value Market Share by Type in 2023
1.3.3 Class A OTC Drug
1.3.4 Class B OTC Drug
1.4 Global OTC Drug Market by Application
1.4.1 Overview: Global OTC Drug Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Household
1.5 Global OTC Drug Market Size & Forecast
1.6 Global OTC Drug Market Size and Forecast by Region
1.6.1 Global OTC Drug Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global OTC Drug Market Size by Region, (2019-2030)
1.6.3 North America OTC Drug Market Size and Prospect (2019-2030)
1.6.4 Europe OTC Drug Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific OTC Drug Market Size and Prospect (2019-2030)
1.6.6 South America OTC Drug Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa OTC Drug Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Bayer HealthCare
2.1.1 Bayer HealthCare Details
2.1.2 Bayer HealthCare Major Business
2.1.3 Bayer HealthCare OTC Drug Product and Solutions
2.1.4 Bayer HealthCare OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bayer HealthCare Recent Developments and Future Plans
2.2 GlaxoSmithKline(GSK)
2.2.1 GlaxoSmithKline(GSK) Details
2.2.2 GlaxoSmithKline(GSK) Major Business
2.2.3 GlaxoSmithKline(GSK) OTC Drug Product and Solutions
2.2.4 GlaxoSmithKline(GSK) OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GlaxoSmithKline(GSK) Recent Developments and Future Plans
2.3 Johnson&Johnson
2.3.1 Johnson&Johnson Details
2.3.2 Johnson&Johnson Major Business
2.3.3 Johnson&Johnson OTC Drug Product and Solutions
2.3.4 Johnson&Johnson OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Johnson&Johnson Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer OTC Drug Product and Solutions
2.4.4 Pfizer OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi OTC Drug Product and Solutions
2.5.4 Sanofi OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca OTC Drug Product and Solutions
2.6.4 AstraZeneca OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 BioGaia
2.7.1 BioGaia Details
2.7.2 BioGaia Major Business
2.7.3 BioGaia OTC Drug Product and Solutions
2.7.4 BioGaia OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 BioGaia Recent Developments and Future Plans
2.8 Bristol Myers Squibb
2.8.1 Bristol Myers Squibb Details
2.8.2 Bristol Myers Squibb Major Business
2.8.3 Bristol Myers Squibb OTC Drug Product and Solutions
2.8.4 Bristol Myers Squibb OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bristol Myers Squibb Recent Developments and Future Plans
2.9 Bukwang Pharmaceutica
2.9.1 Bukwang Pharmaceutica Details
2.9.2 Bukwang Pharmaceutica Major Business
2.9.3 Bukwang Pharmaceutica OTC Drug Product and Solutions
2.9.4 Bukwang Pharmaceutica OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Bukwang Pharmaceutica Recent Developments and Future Plans
2.10 Chr. Hansen
2.10.1 Chr. Hansen Details
2.10.2 Chr. Hansen Major Business
2.10.3 Chr. Hansen OTC Drug Product and Solutions
2.10.4 Chr. Hansen OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Chr. Hansen Recent Developments and Future Plans
2.11 Cipla
2.11.1 Cipla Details
2.11.2 Cipla Major Business
2.11.3 Cipla OTC Drug Product and Solutions
2.11.4 Cipla OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Cipla Recent Developments and Future Plans
2.12 CoLucid
2.12.1 CoLucid Details
2.12.2 CoLucid Major Business
2.12.3 CoLucid OTC Drug Product and Solutions
2.12.4 CoLucid OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 CoLucid Recent Developments and Future Plans
2.13 Daiichi Sankyo
2.13.1 Daiichi Sankyo Details
2.13.2 Daiichi Sankyo Major Business
2.13.3 Daiichi Sankyo OTC Drug Product and Solutions
2.13.4 Daiichi Sankyo OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Daiichi Sankyo Recent Developments and Future Plans
2.14 Friggs
2.14.1 Friggs Details
2.14.2 Friggs Major Business
2.14.3 Friggs OTC Drug Product and Solutions
2.14.4 Friggs OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Friggs Recent Developments and Future Plans
2.15 DSM
2.15.1 DSM Details
2.15.2 DSM Major Business
2.15.3 DSM OTC Drug Product and Solutions
2.15.4 DSM OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 DSM Recent Developments and Future Plans
2.16 Eisai
2.16.1 Eisai Details
2.16.2 Eisai Major Business
2.16.3 Eisai OTC Drug Product and Solutions
2.16.4 Eisai OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Eisai Recent Developments and Future Plans
2.17 Eli Lilly
2.17.1 Eli Lilly Details
2.17.2 Eli Lilly Major Business
2.17.3 Eli Lilly OTC Drug Product and Solutions
2.17.4 Eli Lilly OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Eli Lilly Recent Developments and Future Plans
2.18 Herbalife
2.18.1 Herbalife Details
2.18.2 Herbalife Major Business
2.18.3 Herbalife OTC Drug Product and Solutions
2.18.4 Herbalife OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Herbalife Recent Developments and Future Plans
2.19 Euradite
2.19.1 Euradite Details
2.19.2 Euradite Major Business
2.19.3 Euradite OTC Drug Product and Solutions
2.19.4 Euradite OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Euradite Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global OTC Drug Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of OTC Drug by Company Revenue
3.2.2 Top 3 OTC Drug Players Market Share in 2023
3.2.3 Top 6 OTC Drug Players Market Share in 2023
3.3 OTC Drug Market: Overall Company Footprint Analysis
3.3.1 OTC Drug Market: Region Footprint
3.3.2 OTC Drug Market: Company Product Type Footprint
3.3.3 OTC Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global OTC Drug Consumption Value and Market Share by Type (2019-2024)
4.2 Global OTC Drug Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global OTC Drug Consumption Value Market Share by Application (2019-2024)
5.2 Global OTC Drug Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America OTC Drug Consumption Value by Type (2019-2030)
6.2 North America OTC Drug Consumption Value by Application (2019-2030)
6.3 North America OTC Drug Market Size by Country
6.3.1 North America OTC Drug Consumption Value by Country (2019-2030)
6.3.2 United States OTC Drug Market Size and Forecast (2019-2030)
6.3.3 Canada OTC Drug Market Size and Forecast (2019-2030)
6.3.4 Mexico OTC Drug Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe OTC Drug Consumption Value by Type (2019-2030)
7.2 Europe OTC Drug Consumption Value by Application (2019-2030)
7.3 Europe OTC Drug Market Size by Country
7.3.1 Europe OTC Drug Consumption Value by Country (2019-2030)
7.3.2 Germany OTC Drug Market Size and Forecast (2019-2030)
7.3.3 France OTC Drug Market Size and Forecast (2019-2030)
7.3.4 United Kingdom OTC Drug Market Size and Forecast (2019-2030)
7.3.5 Russia OTC Drug Market Size and Forecast (2019-2030)
7.3.6 Italy OTC Drug Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific OTC Drug Consumption Value by Type (2019-2030)
8.2 Asia-Pacific OTC Drug Consumption Value by Application (2019-2030)
8.3 Asia-Pacific OTC Drug Market Size by Region
8.3.1 Asia-Pacific OTC Drug Consumption Value by Region (2019-2030)
8.3.2 China OTC Drug Market Size and Forecast (2019-2030)
8.3.3 Japan OTC Drug Market Size and Forecast (2019-2030)
8.3.4 South Korea OTC Drug Market Size and Forecast (2019-2030)
8.3.5 India OTC Drug Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia OTC Drug Market Size and Forecast (2019-2030)
8.3.7 Australia OTC Drug Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America OTC Drug Consumption Value by Type (2019-2030)
9.2 South America OTC Drug Consumption Value by Application (2019-2030)
9.3 South America OTC Drug Market Size by Country
9.3.1 South America OTC Drug Consumption Value by Country (2019-2030)
9.3.2 Brazil OTC Drug Market Size and Forecast (2019-2030)
9.3.3 Argentina OTC Drug Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa OTC Drug Consumption Value by Type (2019-2030)
10.2 Middle East & Africa OTC Drug Consumption Value by Application (2019-2030)
10.3 Middle East & Africa OTC Drug Market Size by Country
10.3.1 Middle East & Africa OTC Drug Consumption Value by Country (2019-2030)
10.3.2 Turkey OTC Drug Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia OTC Drug Market Size and Forecast (2019-2030)
10.3.4 UAE OTC Drug Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 OTC Drug Market Drivers
11.2 OTC Drug Market Restraints
11.3 OTC Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 OTC Drug Industry Chain
12.2 OTC Drug Upstream Analysis
12.3 OTC Drug Midstream Analysis
12.4 OTC Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of OTC Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of OTC Drug by Type
1.3.1 Overview: Global OTC Drug Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global OTC Drug Consumption Value Market Share by Type in 2023
1.3.3 Class A OTC Drug
1.3.4 Class B OTC Drug
1.4 Global OTC Drug Market by Application
1.4.1 Overview: Global OTC Drug Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Household
1.5 Global OTC Drug Market Size & Forecast
1.6 Global OTC Drug Market Size and Forecast by Region
1.6.1 Global OTC Drug Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global OTC Drug Market Size by Region, (2019-2030)
1.6.3 North America OTC Drug Market Size and Prospect (2019-2030)
1.6.4 Europe OTC Drug Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific OTC Drug Market Size and Prospect (2019-2030)
1.6.6 South America OTC Drug Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa OTC Drug Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Bayer HealthCare
2.1.1 Bayer HealthCare Details
2.1.2 Bayer HealthCare Major Business
2.1.3 Bayer HealthCare OTC Drug Product and Solutions
2.1.4 Bayer HealthCare OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bayer HealthCare Recent Developments and Future Plans
2.2 GlaxoSmithKline(GSK)
2.2.1 GlaxoSmithKline(GSK) Details
2.2.2 GlaxoSmithKline(GSK) Major Business
2.2.3 GlaxoSmithKline(GSK) OTC Drug Product and Solutions
2.2.4 GlaxoSmithKline(GSK) OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GlaxoSmithKline(GSK) Recent Developments and Future Plans
2.3 Johnson&Johnson
2.3.1 Johnson&Johnson Details
2.3.2 Johnson&Johnson Major Business
2.3.3 Johnson&Johnson OTC Drug Product and Solutions
2.3.4 Johnson&Johnson OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Johnson&Johnson Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer OTC Drug Product and Solutions
2.4.4 Pfizer OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi OTC Drug Product and Solutions
2.5.4 Sanofi OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca OTC Drug Product and Solutions
2.6.4 AstraZeneca OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 BioGaia
2.7.1 BioGaia Details
2.7.2 BioGaia Major Business
2.7.3 BioGaia OTC Drug Product and Solutions
2.7.4 BioGaia OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 BioGaia Recent Developments and Future Plans
2.8 Bristol Myers Squibb
2.8.1 Bristol Myers Squibb Details
2.8.2 Bristol Myers Squibb Major Business
2.8.3 Bristol Myers Squibb OTC Drug Product and Solutions
2.8.4 Bristol Myers Squibb OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bristol Myers Squibb Recent Developments and Future Plans
2.9 Bukwang Pharmaceutica
2.9.1 Bukwang Pharmaceutica Details
2.9.2 Bukwang Pharmaceutica Major Business
2.9.3 Bukwang Pharmaceutica OTC Drug Product and Solutions
2.9.4 Bukwang Pharmaceutica OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Bukwang Pharmaceutica Recent Developments and Future Plans
2.10 Chr. Hansen
2.10.1 Chr. Hansen Details
2.10.2 Chr. Hansen Major Business
2.10.3 Chr. Hansen OTC Drug Product and Solutions
2.10.4 Chr. Hansen OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Chr. Hansen Recent Developments and Future Plans
2.11 Cipla
2.11.1 Cipla Details
2.11.2 Cipla Major Business
2.11.3 Cipla OTC Drug Product and Solutions
2.11.4 Cipla OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Cipla Recent Developments and Future Plans
2.12 CoLucid
2.12.1 CoLucid Details
2.12.2 CoLucid Major Business
2.12.3 CoLucid OTC Drug Product and Solutions
2.12.4 CoLucid OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 CoLucid Recent Developments and Future Plans
2.13 Daiichi Sankyo
2.13.1 Daiichi Sankyo Details
2.13.2 Daiichi Sankyo Major Business
2.13.3 Daiichi Sankyo OTC Drug Product and Solutions
2.13.4 Daiichi Sankyo OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Daiichi Sankyo Recent Developments and Future Plans
2.14 Friggs
2.14.1 Friggs Details
2.14.2 Friggs Major Business
2.14.3 Friggs OTC Drug Product and Solutions
2.14.4 Friggs OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Friggs Recent Developments and Future Plans
2.15 DSM
2.15.1 DSM Details
2.15.2 DSM Major Business
2.15.3 DSM OTC Drug Product and Solutions
2.15.4 DSM OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 DSM Recent Developments and Future Plans
2.16 Eisai
2.16.1 Eisai Details
2.16.2 Eisai Major Business
2.16.3 Eisai OTC Drug Product and Solutions
2.16.4 Eisai OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Eisai Recent Developments and Future Plans
2.17 Eli Lilly
2.17.1 Eli Lilly Details
2.17.2 Eli Lilly Major Business
2.17.3 Eli Lilly OTC Drug Product and Solutions
2.17.4 Eli Lilly OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Eli Lilly Recent Developments and Future Plans
2.18 Herbalife
2.18.1 Herbalife Details
2.18.2 Herbalife Major Business
2.18.3 Herbalife OTC Drug Product and Solutions
2.18.4 Herbalife OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Herbalife Recent Developments and Future Plans
2.19 Euradite
2.19.1 Euradite Details
2.19.2 Euradite Major Business
2.19.3 Euradite OTC Drug Product and Solutions
2.19.4 Euradite OTC Drug Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Euradite Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global OTC Drug Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of OTC Drug by Company Revenue
3.2.2 Top 3 OTC Drug Players Market Share in 2023
3.2.3 Top 6 OTC Drug Players Market Share in 2023
3.3 OTC Drug Market: Overall Company Footprint Analysis
3.3.1 OTC Drug Market: Region Footprint
3.3.2 OTC Drug Market: Company Product Type Footprint
3.3.3 OTC Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global OTC Drug Consumption Value and Market Share by Type (2019-2024)
4.2 Global OTC Drug Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global OTC Drug Consumption Value Market Share by Application (2019-2024)
5.2 Global OTC Drug Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America OTC Drug Consumption Value by Type (2019-2030)
6.2 North America OTC Drug Consumption Value by Application (2019-2030)
6.3 North America OTC Drug Market Size by Country
6.3.1 North America OTC Drug Consumption Value by Country (2019-2030)
6.3.2 United States OTC Drug Market Size and Forecast (2019-2030)
6.3.3 Canada OTC Drug Market Size and Forecast (2019-2030)
6.3.4 Mexico OTC Drug Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe OTC Drug Consumption Value by Type (2019-2030)
7.2 Europe OTC Drug Consumption Value by Application (2019-2030)
7.3 Europe OTC Drug Market Size by Country
7.3.1 Europe OTC Drug Consumption Value by Country (2019-2030)
7.3.2 Germany OTC Drug Market Size and Forecast (2019-2030)
7.3.3 France OTC Drug Market Size and Forecast (2019-2030)
7.3.4 United Kingdom OTC Drug Market Size and Forecast (2019-2030)
7.3.5 Russia OTC Drug Market Size and Forecast (2019-2030)
7.3.6 Italy OTC Drug Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific OTC Drug Consumption Value by Type (2019-2030)
8.2 Asia-Pacific OTC Drug Consumption Value by Application (2019-2030)
8.3 Asia-Pacific OTC Drug Market Size by Region
8.3.1 Asia-Pacific OTC Drug Consumption Value by Region (2019-2030)
8.3.2 China OTC Drug Market Size and Forecast (2019-2030)
8.3.3 Japan OTC Drug Market Size and Forecast (2019-2030)
8.3.4 South Korea OTC Drug Market Size and Forecast (2019-2030)
8.3.5 India OTC Drug Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia OTC Drug Market Size and Forecast (2019-2030)
8.3.7 Australia OTC Drug Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America OTC Drug Consumption Value by Type (2019-2030)
9.2 South America OTC Drug Consumption Value by Application (2019-2030)
9.3 South America OTC Drug Market Size by Country
9.3.1 South America OTC Drug Consumption Value by Country (2019-2030)
9.3.2 Brazil OTC Drug Market Size and Forecast (2019-2030)
9.3.3 Argentina OTC Drug Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa OTC Drug Consumption Value by Type (2019-2030)
10.2 Middle East & Africa OTC Drug Consumption Value by Application (2019-2030)
10.3 Middle East & Africa OTC Drug Market Size by Country
10.3.1 Middle East & Africa OTC Drug Consumption Value by Country (2019-2030)
10.3.2 Turkey OTC Drug Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia OTC Drug Market Size and Forecast (2019-2030)
10.3.4 UAE OTC Drug Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 OTC Drug Market Drivers
11.2 OTC Drug Market Restraints
11.3 OTC Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 OTC Drug Industry Chain
12.2 OTC Drug Upstream Analysis
12.3 OTC Drug Midstream Analysis
12.4 OTC Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global OTC Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global OTC Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global OTC Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global OTC Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Bayer HealthCare Company Information, Head Office, and Major Competitors
Table 6. Bayer HealthCare Major Business
Table 7. Bayer HealthCare OTC Drug Product and Solutions
Table 8. Bayer HealthCare OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Bayer HealthCare Recent Developments and Future Plans
Table 10. GlaxoSmithKline(GSK) Company Information, Head Office, and Major Competitors
Table 11. GlaxoSmithKline(GSK) Major Business
Table 12. GlaxoSmithKline(GSK) OTC Drug Product and Solutions
Table 13. GlaxoSmithKline(GSK) OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. GlaxoSmithKline(GSK) Recent Developments and Future Plans
Table 15. Johnson&Johnson Company Information, Head Office, and Major Competitors
Table 16. Johnson&Johnson Major Business
Table 17. Johnson&Johnson OTC Drug Product and Solutions
Table 18. Johnson&Johnson OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Johnson&Johnson Recent Developments and Future Plans
Table 20. Pfizer Company Information, Head Office, and Major Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer OTC Drug Product and Solutions
Table 23. Pfizer OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Pfizer Recent Developments and Future Plans
Table 25. Sanofi Company Information, Head Office, and Major Competitors
Table 26. Sanofi Major Business
Table 27. Sanofi OTC Drug Product and Solutions
Table 28. Sanofi OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sanofi Recent Developments and Future Plans
Table 30. AstraZeneca Company Information, Head Office, and Major Competitors
Table 31. AstraZeneca Major Business
Table 32. AstraZeneca OTC Drug Product and Solutions
Table 33. AstraZeneca OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. AstraZeneca Recent Developments and Future Plans
Table 35. BioGaia Company Information, Head Office, and Major Competitors
Table 36. BioGaia Major Business
Table 37. BioGaia OTC Drug Product and Solutions
Table 38. BioGaia OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. BioGaia Recent Developments and Future Plans
Table 40. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
Table 41. Bristol Myers Squibb Major Business
Table 42. Bristol Myers Squibb OTC Drug Product and Solutions
Table 43. Bristol Myers Squibb OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bristol Myers Squibb Recent Developments and Future Plans
Table 45. Bukwang Pharmaceutica Company Information, Head Office, and Major Competitors
Table 46. Bukwang Pharmaceutica Major Business
Table 47. Bukwang Pharmaceutica OTC Drug Product and Solutions
Table 48. Bukwang Pharmaceutica OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Bukwang Pharmaceutica Recent Developments and Future Plans
Table 50. Chr. Hansen Company Information, Head Office, and Major Competitors
Table 51. Chr. Hansen Major Business
Table 52. Chr. Hansen OTC Drug Product and Solutions
Table 53. Chr. Hansen OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Chr. Hansen Recent Developments and Future Plans
Table 55. Cipla Company Information, Head Office, and Major Competitors
Table 56. Cipla Major Business
Table 57. Cipla OTC Drug Product and Solutions
Table 58. Cipla OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Cipla Recent Developments and Future Plans
Table 60. CoLucid Company Information, Head Office, and Major Competitors
Table 61. CoLucid Major Business
Table 62. CoLucid OTC Drug Product and Solutions
Table 63. CoLucid OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. CoLucid Recent Developments and Future Plans
Table 65. Daiichi Sankyo Company Information, Head Office, and Major Competitors
Table 66. Daiichi Sankyo Major Business
Table 67. Daiichi Sankyo OTC Drug Product and Solutions
Table 68. Daiichi Sankyo OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Daiichi Sankyo Recent Developments and Future Plans
Table 70. Friggs Company Information, Head Office, and Major Competitors
Table 71. Friggs Major Business
Table 72. Friggs OTC Drug Product and Solutions
Table 73. Friggs OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Friggs Recent Developments and Future Plans
Table 75. DSM Company Information, Head Office, and Major Competitors
Table 76. DSM Major Business
Table 77. DSM OTC Drug Product and Solutions
Table 78. DSM OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. DSM Recent Developments and Future Plans
Table 80. Eisai Company Information, Head Office, and Major Competitors
Table 81. Eisai Major Business
Table 82. Eisai OTC Drug Product and Solutions
Table 83. Eisai OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Eisai Recent Developments and Future Plans
Table 85. Eli Lilly Company Information, Head Office, and Major Competitors
Table 86. Eli Lilly Major Business
Table 87. Eli Lilly OTC Drug Product and Solutions
Table 88. Eli Lilly OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Eli Lilly Recent Developments and Future Plans
Table 90. Herbalife Company Information, Head Office, and Major Competitors
Table 91. Herbalife Major Business
Table 92. Herbalife OTC Drug Product and Solutions
Table 93. Herbalife OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Herbalife Recent Developments and Future Plans
Table 95. Euradite Company Information, Head Office, and Major Competitors
Table 96. Euradite Major Business
Table 97. Euradite OTC Drug Product and Solutions
Table 98. Euradite OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Euradite Recent Developments and Future Plans
Table 100. Global OTC Drug Revenue (USD Million) by Players (2019-2024)
Table 101. Global OTC Drug Revenue Share by Players (2019-2024)
Table 102. Breakdown of OTC Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in OTC Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 104. Head Office of Key OTC Drug Players
Table 105. OTC Drug Market: Company Product Type Footprint
Table 106. OTC Drug Market: Company Product Application Footprint
Table 107. OTC Drug New Market Entrants and Barriers to Market Entry
Table 108. OTC Drug Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global OTC Drug Consumption Value (USD Million) by Type (2019-2024)
Table 110. Global OTC Drug Consumption Value Share by Type (2019-2024)
Table 111. Global OTC Drug Consumption Value Forecast by Type (2025-2030)
Table 112. Global OTC Drug Consumption Value by Application (2019-2024)
Table 113. Global OTC Drug Consumption Value Forecast by Application (2025-2030)
Table 114. North America OTC Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 115. North America OTC Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 116. North America OTC Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 117. North America OTC Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 118. North America OTC Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 119. North America OTC Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 120. Europe OTC Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Europe OTC Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Europe OTC Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 123. Europe OTC Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 124. Europe OTC Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe OTC Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific OTC Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 127. Asia-Pacific OTC Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 128. Asia-Pacific OTC Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 129. Asia-Pacific OTC Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 130. Asia-Pacific OTC Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 131. Asia-Pacific OTC Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 132. South America OTC Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 133. South America OTC Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 134. South America OTC Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 135. South America OTC Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 136. South America OTC Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 137. South America OTC Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Middle East & Africa OTC Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 139. Middle East & Africa OTC Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 140. Middle East & Africa OTC Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 141. Middle East & Africa OTC Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 142. Middle East & Africa OTC Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 143. Middle East & Africa OTC Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 144. OTC Drug Raw Material
Table 145. Key Suppliers of OTC Drug Raw Materials
Table 1. Global OTC Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global OTC Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global OTC Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global OTC Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Bayer HealthCare Company Information, Head Office, and Major Competitors
Table 6. Bayer HealthCare Major Business
Table 7. Bayer HealthCare OTC Drug Product and Solutions
Table 8. Bayer HealthCare OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Bayer HealthCare Recent Developments and Future Plans
Table 10. GlaxoSmithKline(GSK) Company Information, Head Office, and Major Competitors
Table 11. GlaxoSmithKline(GSK) Major Business
Table 12. GlaxoSmithKline(GSK) OTC Drug Product and Solutions
Table 13. GlaxoSmithKline(GSK) OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. GlaxoSmithKline(GSK) Recent Developments and Future Plans
Table 15. Johnson&Johnson Company Information, Head Office, and Major Competitors
Table 16. Johnson&Johnson Major Business
Table 17. Johnson&Johnson OTC Drug Product and Solutions
Table 18. Johnson&Johnson OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Johnson&Johnson Recent Developments and Future Plans
Table 20. Pfizer Company Information, Head Office, and Major Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer OTC Drug Product and Solutions
Table 23. Pfizer OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Pfizer Recent Developments and Future Plans
Table 25. Sanofi Company Information, Head Office, and Major Competitors
Table 26. Sanofi Major Business
Table 27. Sanofi OTC Drug Product and Solutions
Table 28. Sanofi OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sanofi Recent Developments and Future Plans
Table 30. AstraZeneca Company Information, Head Office, and Major Competitors
Table 31. AstraZeneca Major Business
Table 32. AstraZeneca OTC Drug Product and Solutions
Table 33. AstraZeneca OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. AstraZeneca Recent Developments and Future Plans
Table 35. BioGaia Company Information, Head Office, and Major Competitors
Table 36. BioGaia Major Business
Table 37. BioGaia OTC Drug Product and Solutions
Table 38. BioGaia OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. BioGaia Recent Developments and Future Plans
Table 40. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
Table 41. Bristol Myers Squibb Major Business
Table 42. Bristol Myers Squibb OTC Drug Product and Solutions
Table 43. Bristol Myers Squibb OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bristol Myers Squibb Recent Developments and Future Plans
Table 45. Bukwang Pharmaceutica Company Information, Head Office, and Major Competitors
Table 46. Bukwang Pharmaceutica Major Business
Table 47. Bukwang Pharmaceutica OTC Drug Product and Solutions
Table 48. Bukwang Pharmaceutica OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Bukwang Pharmaceutica Recent Developments and Future Plans
Table 50. Chr. Hansen Company Information, Head Office, and Major Competitors
Table 51. Chr. Hansen Major Business
Table 52. Chr. Hansen OTC Drug Product and Solutions
Table 53. Chr. Hansen OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Chr. Hansen Recent Developments and Future Plans
Table 55. Cipla Company Information, Head Office, and Major Competitors
Table 56. Cipla Major Business
Table 57. Cipla OTC Drug Product and Solutions
Table 58. Cipla OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Cipla Recent Developments and Future Plans
Table 60. CoLucid Company Information, Head Office, and Major Competitors
Table 61. CoLucid Major Business
Table 62. CoLucid OTC Drug Product and Solutions
Table 63. CoLucid OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. CoLucid Recent Developments and Future Plans
Table 65. Daiichi Sankyo Company Information, Head Office, and Major Competitors
Table 66. Daiichi Sankyo Major Business
Table 67. Daiichi Sankyo OTC Drug Product and Solutions
Table 68. Daiichi Sankyo OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Daiichi Sankyo Recent Developments and Future Plans
Table 70. Friggs Company Information, Head Office, and Major Competitors
Table 71. Friggs Major Business
Table 72. Friggs OTC Drug Product and Solutions
Table 73. Friggs OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Friggs Recent Developments and Future Plans
Table 75. DSM Company Information, Head Office, and Major Competitors
Table 76. DSM Major Business
Table 77. DSM OTC Drug Product and Solutions
Table 78. DSM OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. DSM Recent Developments and Future Plans
Table 80. Eisai Company Information, Head Office, and Major Competitors
Table 81. Eisai Major Business
Table 82. Eisai OTC Drug Product and Solutions
Table 83. Eisai OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Eisai Recent Developments and Future Plans
Table 85. Eli Lilly Company Information, Head Office, and Major Competitors
Table 86. Eli Lilly Major Business
Table 87. Eli Lilly OTC Drug Product and Solutions
Table 88. Eli Lilly OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Eli Lilly Recent Developments and Future Plans
Table 90. Herbalife Company Information, Head Office, and Major Competitors
Table 91. Herbalife Major Business
Table 92. Herbalife OTC Drug Product and Solutions
Table 93. Herbalife OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Herbalife Recent Developments and Future Plans
Table 95. Euradite Company Information, Head Office, and Major Competitors
Table 96. Euradite Major Business
Table 97. Euradite OTC Drug Product and Solutions
Table 98. Euradite OTC Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Euradite Recent Developments and Future Plans
Table 100. Global OTC Drug Revenue (USD Million) by Players (2019-2024)
Table 101. Global OTC Drug Revenue Share by Players (2019-2024)
Table 102. Breakdown of OTC Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in OTC Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 104. Head Office of Key OTC Drug Players
Table 105. OTC Drug Market: Company Product Type Footprint
Table 106. OTC Drug Market: Company Product Application Footprint
Table 107. OTC Drug New Market Entrants and Barriers to Market Entry
Table 108. OTC Drug Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global OTC Drug Consumption Value (USD Million) by Type (2019-2024)
Table 110. Global OTC Drug Consumption Value Share by Type (2019-2024)
Table 111. Global OTC Drug Consumption Value Forecast by Type (2025-2030)
Table 112. Global OTC Drug Consumption Value by Application (2019-2024)
Table 113. Global OTC Drug Consumption Value Forecast by Application (2025-2030)
Table 114. North America OTC Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 115. North America OTC Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 116. North America OTC Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 117. North America OTC Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 118. North America OTC Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 119. North America OTC Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 120. Europe OTC Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Europe OTC Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Europe OTC Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 123. Europe OTC Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 124. Europe OTC Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe OTC Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific OTC Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 127. Asia-Pacific OTC Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 128. Asia-Pacific OTC Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 129. Asia-Pacific OTC Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 130. Asia-Pacific OTC Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 131. Asia-Pacific OTC Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 132. South America OTC Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 133. South America OTC Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 134. South America OTC Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 135. South America OTC Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 136. South America OTC Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 137. South America OTC Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Middle East & Africa OTC Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 139. Middle East & Africa OTC Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 140. Middle East & Africa OTC Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 141. Middle East & Africa OTC Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 142. Middle East & Africa OTC Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 143. Middle East & Africa OTC Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 144. OTC Drug Raw Material
Table 145. Key Suppliers of OTC Drug Raw Materials
LIST OF FIGURES
Figure 1. OTC Drug Picture
Figure 2. Global OTC Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global OTC Drug Consumption Value Market Share by Type in 2023
Figure 4. Class A OTC Drug
Figure 5. Class B OTC Drug
Figure 6. Global OTC Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. OTC Drug Consumption Value Market Share by Application in 2023
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Household Picture
Figure 11. Global OTC Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global OTC Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market OTC Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global OTC Drug Consumption Value Market Share by Region (2019-2030)
Figure 15. Global OTC Drug Consumption Value Market Share by Region in 2023
Figure 16. North America OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 19. South America OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 21. Global OTC Drug Revenue Share by Players in 2023
Figure 22. OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players OTC Drug Market Share in 2023
Figure 24. Global Top 6 Players OTC Drug Market Share in 2023
Figure 25. Global OTC Drug Consumption Value Share by Type (2019-2024)
Figure 26. Global OTC Drug Market Share Forecast by Type (2025-2030)
Figure 27. Global OTC Drug Consumption Value Share by Application (2019-2024)
Figure 28. Global OTC Drug Market Share Forecast by Application (2025-2030)
Figure 29. North America OTC Drug Consumption Value Market Share by Type (2019-2030)
Figure 30. North America OTC Drug Consumption Value Market Share by Application (2019-2030)
Figure 31. North America OTC Drug Consumption Value Market Share by Country (2019-2030)
Figure 32. United States OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe OTC Drug Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe OTC Drug Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe OTC Drug Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 39. France OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific OTC Drug Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific OTC Drug Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific OTC Drug Consumption Value Market Share by Region (2019-2030)
Figure 46. China OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 49. India OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 52. South America OTC Drug Consumption Value Market Share by Type (2019-2030)
Figure 53. South America OTC Drug Consumption Value Market Share by Application (2019-2030)
Figure 54. South America OTC Drug Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa OTC Drug Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa OTC Drug Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa OTC Drug Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 63. OTC Drug Market Drivers
Figure 64. OTC Drug Market Restraints
Figure 65. OTC Drug Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of OTC Drug in 2023
Figure 68. Manufacturing Process Analysis of OTC Drug
Figure 69. OTC Drug Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. OTC Drug Picture
Figure 2. Global OTC Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global OTC Drug Consumption Value Market Share by Type in 2023
Figure 4. Class A OTC Drug
Figure 5. Class B OTC Drug
Figure 6. Global OTC Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. OTC Drug Consumption Value Market Share by Application in 2023
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Household Picture
Figure 11. Global OTC Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global OTC Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market OTC Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global OTC Drug Consumption Value Market Share by Region (2019-2030)
Figure 15. Global OTC Drug Consumption Value Market Share by Region in 2023
Figure 16. North America OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 19. South America OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 21. Global OTC Drug Revenue Share by Players in 2023
Figure 22. OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players OTC Drug Market Share in 2023
Figure 24. Global Top 6 Players OTC Drug Market Share in 2023
Figure 25. Global OTC Drug Consumption Value Share by Type (2019-2024)
Figure 26. Global OTC Drug Market Share Forecast by Type (2025-2030)
Figure 27. Global OTC Drug Consumption Value Share by Application (2019-2024)
Figure 28. Global OTC Drug Market Share Forecast by Application (2025-2030)
Figure 29. North America OTC Drug Consumption Value Market Share by Type (2019-2030)
Figure 30. North America OTC Drug Consumption Value Market Share by Application (2019-2030)
Figure 31. North America OTC Drug Consumption Value Market Share by Country (2019-2030)
Figure 32. United States OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe OTC Drug Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe OTC Drug Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe OTC Drug Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 39. France OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific OTC Drug Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific OTC Drug Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific OTC Drug Consumption Value Market Share by Region (2019-2030)
Figure 46. China OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 49. India OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 52. South America OTC Drug Consumption Value Market Share by Type (2019-2030)
Figure 53. South America OTC Drug Consumption Value Market Share by Application (2019-2030)
Figure 54. South America OTC Drug Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa OTC Drug Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa OTC Drug Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa OTC Drug Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE OTC Drug Consumption Value (2019-2030) & (USD Million)
Figure 63. OTC Drug Market Drivers
Figure 64. OTC Drug Market Restraints
Figure 65. OTC Drug Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of OTC Drug in 2023
Figure 68. Manufacturing Process Analysis of OTC Drug
Figure 69. OTC Drug Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
